¡Hola! Iniciá sesión
Inicio > Productos

Study Guide for Lehne's Pharmacology for Nursing Care

$70.182,00
10% de descuento pagando con Transferencia
Ver más detalles

FORMATO

Edicion

PAPEL

Edicion

EBOOK
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

  • Reinforcement of key information equips you for success on the NCLEX® Examination and for patient safety (a QSEN core competency) in clinical practice.
  • NCLEX Examination-style questions include multiple-choice, multiple-select, and alternate-item formats, promoting learner engagement and preparing you for success on the NCLEX Exam and for safe clinical practice.
  • Three-part chapter organization separates content into 1) study questions, 2) NCLEX review and application questions, and 3) dosage calculation questions.
  • Prioritization and delegation questions emphasize skills related to prioritization and delegation, both of which are increasingly being tested on the NCLEX Exam, and are highlighted by special icons.
  • Focus on implications of drugs and drug classes for patient care includes activities and questions that are designed for you to answer "How do the drugs work in the body?" and "How do these drug actions impact patient care?"
  • Application- and analysis-level questions are highlighted by special icons, and ask you to integrate other nursing knowledge such as developmental considerations, laboratory values, and symptoms of adverse effects.
  • Detailed rationales for all prioritization questions are included in the answer key and include explanations for both correct and incorrect responses.
  • Answer key is included in the back of the print study guide.

1. Introduction - p. iii 2. Unit One: Introduction - p. iii 3. 1: Orientation to Pharmacology - p. 1 4. 2: Application of Pharmacology in Nursing Practice - p. 3 5. 3: Drug Regulation, Development, Names, and Information - p. 5 6. Unit Two: Basic Principles of Pharmacology - p. 6 7. 4: Pharmacokinetics - p. 7 8. 5: Pharmacodynamics - p. 9 9. 6: Drug Interactions - p. 11 10. 7: Adverse Drug Reactions and Medication Errors - p. 13 11. 8: Individual Variation to Drug Responses - p. 15 12. 9: Genetic and Genomic Considerations - p. 17 13. 10: Introduction to Immunomodulators - p. 19 14. Unit Three: Drug Therapy Across the Life Span - p. 20 15. 11: Drug Therapy During Pregnancy and Breast-Feeding - p. 21 16. 12: Drug Therapy in Pediatric Patients - p. 23 17. 13: Drug Therapy in Older Adult Patients - p. 25 18. Unit Four: Peripheral Nervous System Drugs - p. 26 19. 14: Basic Principles of Neuropharmacology - p. 27 20. 15: Physiology of the Peripheral Nervous System - p. 29 21. 16: Muscarinic Agonists - p. 31 22. 17: Muscarinic Antagonists - p. 33 23. 18: Cholinesterase Inhibitors and Their Use in Myasthenia Gravis - p. 35 24. 19: Drugs that Block Nicotinic Cholinergic Transmission - p. 38 25. 20: Adrenergic Agonists - p. 40 26. 21: Adrenergic Antagonists - p. 42 27. 22: Indirect-Acting Antiadrenergic Agents - p. 45 28. Unit Five: Central Nervous System Drugs - p. 46 29. 23: Introduction to Central Nervous System Pharmacology - p. 47 30. 24: Drugs for Parkinson Disease - p. 48 31. 25: Drugs for Alzheimer Disease - p. 50 32. 26: Drugs for Multiple Sclerosis - p. 52 33. 27: Drugs for Seizure Disorders - p. 55 34. 28: Drugs for Muscle Spasm and Spasticity - p. 59 35. 29: Local Anesthetics - p. 61 36. 30: General Anesthetics - p. 63 37. 31: Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics - p. 66 38. 32: Pain Management in Patients with Cancer - p. 69 39. 33: Drugs for Headache - p. 71 40. 34: Antipsychotic Agents and Their Use in Schizophrenia - p. 74 41. 35: Antidepressants - p. 76 42. 36: Drugs for Bipolar Disorder - p. 80 43. 37: Sedative-Hypnotic Drugs - p. 82 44. 38: Management of Anxiety Disorders - p. 85 45. 39: Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder - p. 88 46. 40: Substance Use Disorders I: Basic Considerations - p. 91 47. 41: Substance Use Disorders II: Alcohol - p. 93 48. 42: Substance Use Disorders III: Nicotine and Smoking - p. 96 49. 43: Substance Use Disorders IV: Major Drugs of Abuse other Than Alcohol and Nicotine - p. 98 50. Unit Six: Drugs that Affect Fluid and Electrolyte Balance - p. 100 51. 44: Diuretics - p. 101 52. 45: Agents Affecting the Volume and Ion Content of Body Fluids - p. 105 53. Unit Seven: Drugs that Affect the Heart, Blood Vessels, and Blood - p. 107 54. 46: Review of Hemodynamics - p. 108 55. 47: Drugs Acting on the Renin-Angiotensin-Aldosterone System - p. 110 56. 48: Calcium Channel Blockers - p. 113 57. 49: Vasodilators - p. 116 58. 50: Drugs for Hypertension - p. 118 59. 51: Drugs for Heart Failure - p. 121 60. 52: Antidysrhythmic Drugs - p. 125 61. 53: Drugs that help Normalize Cholesterol and Triglyceride Levels - p. 128 62. 54: Drugs for Angina Pectoris - p. 131 63. 55: Anticoagulant, Antiplatelet, and Thrombolytic Drugs - p. 134 64. 56: Management of ST-Elevation Myocardial Infarction - p. 138 65. 57: Drugs for Hemophilia - p. 141 66. 58: Drugs for Deficiency Anemias - p. 143 67. 59: Hematopoietic Agents - p. 146 68. Unit Eight: Drugs for Endocrine Disorders - p. 148 69. 60: Drugs for Diabetes Mellitus - p. 149 70. 61: Drugs for Thyroid Disorders - p. 153 71. 62: Drugs Related to Hypothalamic and Pituitary Function - p. 156 72. 63: Drugs for Disorders of the Adrenal Cortex - p. 159 73. Unit Nine: Women’s Health - p. 161 74. 64: Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications - p. 162 75. 65: Birth Control - p. 164 76. 66: Drug Therapy of Infertility - p. 167 77. 67: Drugs that Affect Uterine Function - p. 169 78. Unit Ten: Men’s Health - p. 171 79. 68: Androgens - p. 172 80. 69: Drugs for Male Sexual Dysfunction and Benign Prostatic Hyperplasia - p. 174 81. Unit Eleven: Anti-Inflammatory, Antiallergic, and Immunologic Drugs - p. 176 82. 70: Review of the Immune System - p. 177 83. 71: Childhood Immunization - p. 179 84. 72: Immunosuppressants - p. 183 85. 73: Antihistamines - p. 186 86. 74: Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen - p. 188 87. 75: Glucocorticoids in Nonendocrine Disorders - p. 191 88. Unit Twelve: Drugs for Bone and Joint Disorders - p. 192 89. 76: Drug Therapy of Rheumatoid Arthritis - p. 193 90. 77: Drug Therapy of Gout - p. 196 91. 78: Drugs Affecting Calcium Levels and Bone Mineralization - p. 198 92. Unit Thirteen: Respiratory Tract Drugs - p. 201 93. 79: Drugs for Asthma and Chronic Obstructive Pulmonary Disease - p. 202 94. 80: Drugs for Allergic Rhinitis, Cough, and Colds - p. 206 95. Unit Fourteen: Gastrointestinal Drugs - p. 208 96. 81: Drugs for Peptic Ulcer Disease - p. 209 97. 82: Laxatives - p. 212 98. 83: Other Gastrointestinal Drugs - p. 215 99. Unit Fifteen: Nutrition - p. 217 100. 84: Vitamins - p. 218 101. 85: Drugs for Weight Loss - p. 221 102. 86: Complementary and Alternative Therapy - p. 223 103. Unit Sixteen: Chemotherapy of Infectious Diseases - p. 225 104. 87: Basic Principles of Antimicrobial Therapy - p. 226 105. 88: Drugs That Weaken the Bacterial Cell Wall I: Penicillins - p. 229 106. 89: Drugs That Weaken the Bacterial Cell Wall II: Other Drugs - p. 232 107. 90: Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others - p. 235 108. 91: Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis - p. 238 109. 92: Sulfonamide Antibiotics and Trimethoprim - p. 241 110. 93: Drug Therapy of Urinary Tract Infections - p. 244 111. 94: Antimycobacterial Agents - p. 246 112. 95: Miscellaneous Antibacterial Drugs - p. 250 113. 96: Antifungal Agents - p. 253 114. 97: Antiviral Agents I: Drugs for Non-HIV Viral Infections - p. 256 115. 98: Antiviral Agents II: Drugs for HIV Infection - p. 259 116. 99: Drug Therapy for Sexually Transmitted Infections - p. 262 117. 100: Antiseptics and Disinfectants - p. 265 118. Unit Seventeen: Chemotherapy of Parasitic Diseases - p. 266 119. 101: Anthelmintics - p. 267 120. 102: Antiprotozoal Drugs I: Antimalarial Agents - p. 269 121. 103: Antiprotozoal Drugs II: Miscellaneous Agents - p. 272 122. 104: Ectoparasiticides - p. 274 123. Unit Eighteen: Cancer Chemotherapy - p. 275 124. 105: Basic Principles of Cancer Chemotherapy - p. 276 125. 106: Anticancer Drugs I: Cytotoxic Agents - p. 278 126. 107: Anticancer Drugs II: Noncytotoxic Agents - p. 281 127. Unit Nineteen: Miscellaneous Drugs and Therapies - p. 284 128. 108: Drugs for the Eye - p. 285 129. 109: Drugs for the Skin - p. 288 130. 110: Drugs for the Ear - p. 292 131. Unit Twenty: Toxicology - p. 293 132. 111: Management of Poisoning - p. 294 133. 112: Potential Weapons of Biologic, Radiologic, and Chemical Terrorism - p. 297 134. Answer Key - p. 301 135. Chapter 1 - p. 301 136. Chapter 2 - p. 301 137. Chapter 3 - p. 301 138. Chapter 4 - p. 301 139. Chapter 5 - p. 302 140. Chapter 6 - p. 302 141. Chapter 7 - p. 302 142. Chapter 8 - p. 302 143. Chapter 9 - p. 302 144. Chapter 10 - p. 303 145. Chapter 11 - p. 303 146. Chapter 12 - p. 303 147. Chapter 13 - p. 303 148. Chapter 14 - p. 303 149. Chapter 15 - p. 304 150. Chapter 16 - p. 304 151. Chapter 17 - p. 304 152. Chapter 18 - p. 304 153. Chapter 19 - p. 304 154. Chapter 20 - p. 305 155. Chapter 21 - p. 305 156. Chapter 22 - p. 305 157. Chapter 23 - p. 305 158. Chapter 24 - p. 306 159. Chapter 25 - p. 306 160. Chapter 26 - p. 306 161. Chapter 27 - p. 306 162. Chapter 28 - p. 307 163. Chapter 29 - p. 307 164. Chapter 30 - p. 307 165. Chapter 31 - p. 308 166. Chapter 32 - p. 308 167. Chapter 33 - p. 308 168. Chapter 34 - p. 309 169. Chapter 35 - p. 309 170. Chapter 36 - p. 310 171. Chapter 37 - p. 310 172. Chapter 38 - p. 311 173. Chapter 39 - p. 311 174. Chapter 40 - p. 311 175. Chapter 41 - p. 311 176. Chapter 42 - p. 312 177. Chapter 43 - p. 312 178. Chapter 44 - p. 312 179. Chapter 45 - p. 313 180. Chapter 46 - p. 313 181. Chapter 47 - p. 314 182. Chapter 48 - p. 314 183. Chapter 49 - p. 315 184. Chapter 50 - p. 315 185. Chapter 51 - p. 315 186. Chapter 52 - p. 316 187. Chapter 53 - p. 316 188. Chapter 54 - p. 317 189. Chapter 55 - p. 317 190. Chapter 56 - p. 317 191. Chapter 57 - p. 318 192. Chapter 58 - p. 318 193. Chapter 59 - p. 319 194. Chapter 60 - p. 319 195. Chapter 61 - p. 319 196. Chapter 62 - p. 320 197. Chapter 63 - p. 320 198. Chapter 64 - p. 321 199. Chapter 65 - p. 321 200. Chapter 66 - p. 321 201. Chapter 67 - p. 321 202. Chapter 68 - p. 322 203. Chapter 69 - p. 322 204. Chapter 70 - p. 323 205. Chapter 71 - p. 323 206. Chapter 72 - p. 323 207. Chapter 73 - p. 324 208. Chapter 74 - p. 324 209. Chapter 75 - p. 324 210. Chapter 76 - p. 325 211. Chapter 77 - p. 325 212. Chapter 78 - p. 325 213. Chapter 79 - p. 326 214. Chapter 80 - p. 327 215. Chapter 81 - p. 327 216. Chapter 82 - p. 327 217. Chapter 83 - p. 328 218. Chapter 84 - p. 328 219. Chapter 85 - p. 329 220. Chapter 86 - p. 329 221. Chapter 87 - p. 329 222. Chapter 88 - p. 330 223. Chapter 89 - p. 330 224. Chapter 90 - p. 331 225. Chapter 91 - p. 331 226. Chapter 92 - p. 332 227. Chapter 93 - p. 332 228. Chapter 94 - p. 332 229. Chapter 95 - p. 333 230. Chapter 96 - p. 333 231. Chapter 97 - p. 333 232. Chapter 98 - p. 334 233. Chapter 99 - p. 334 234. Chapter 100 - p. 335 235. Chapter 101 - p. 335 236. Chapter 102 - p. 335 237. Chapter 103 - p. 336 238. Chapter 104 - p. 336 239. Chapter 105 - p. 336 240. Chapter 106 - p. 336 241. Chapter 107 - p. 337 242. Chapter 108 - p. 337 243. Chapter 109 - p. 338 244. Chapter 110 - p. 338 245. Chapter 111 - p. 339 246. Chapter 112 - p. 339

Descripcion
Descripción

  • Reinforcement of key information equips you for success on the NCLEX® Examination and for patient safety (a QSEN core competency) in clinical practice.
  • NCLEX Examination-style questions include multiple-choice, multiple-select, and alternate-item formats, promoting learner engagement and preparing you for success on the NCLEX Exam and for safe clinical practice.
  • Three-part chapter organization separates content into 1) study questions, 2) NCLEX review and application questions, and 3) dosage calculation questions.
  • Prioritization and delegation questions emphasize skills related to prioritization and delegation, both of which are increasingly being tested on the NCLEX Exam, and are highlighted by special icons.
  • Focus on implications of drugs and drug classes for patient care includes activities and questions that are designed for you to answer "How do the drugs work in the body?" and "How do these drug actions impact patient care?"
  • Application- and analysis-level questions are highlighted by special icons, and ask you to integrate other nursing knowledge such as developmental considerations, laboratory values, and symptoms of adverse effects.
  • Detailed rationales for all prioritization questions are included in the answer key and include explanations for both correct and incorrect responses.
  • Answer key is included in the back of the print study guide.

1. Introduction - p. iii 2. Unit One: Introduction - p. iii 3. 1: Orientation to Pharmacology - p. 1 4. 2: Application of Pharmacology in Nursing Practice - p. 3 5. 3: Drug Regulation, Development, Names, and Information - p. 5 6. Unit Two: Basic Principles of Pharmacology - p. 6 7. 4: Pharmacokinetics - p. 7 8. 5: Pharmacodynamics - p. 9 9. 6: Drug Interactions - p. 11 10. 7: Adverse Drug Reactions and Medication Errors - p. 13 11. 8: Individual Variation to Drug Responses - p. 15 12. 9: Genetic and Genomic Considerations - p. 17 13. 10: Introduction to Immunomodulators - p. 19 14. Unit Three: Drug Therapy Across the Life Span - p. 20 15. 11: Drug Therapy During Pregnancy and Breast-Feeding - p. 21 16. 12: Drug Therapy in Pediatric Patients - p. 23 17. 13: Drug Therapy in Older Adult Patients - p. 25 18. Unit Four: Peripheral Nervous System Drugs - p. 26 19. 14: Basic Principles of Neuropharmacology - p. 27 20. 15: Physiology of the Peripheral Nervous System - p. 29 21. 16: Muscarinic Agonists - p. 31 22. 17: Muscarinic Antagonists - p. 33 23. 18: Cholinesterase Inhibitors and Their Use in Myasthenia Gravis - p. 35 24. 19: Drugs that Block Nicotinic Cholinergic Transmission - p. 38 25. 20: Adrenergic Agonists - p. 40 26. 21: Adrenergic Antagonists - p. 42 27. 22: Indirect-Acting Antiadrenergic Agents - p. 45 28. Unit Five: Central Nervous System Drugs - p. 46 29. 23: Introduction to Central Nervous System Pharmacology - p. 47 30. 24: Drugs for Parkinson Disease - p. 48 31. 25: Drugs for Alzheimer Disease - p. 50 32. 26: Drugs for Multiple Sclerosis - p. 52 33. 27: Drugs for Seizure Disorders - p. 55 34. 28: Drugs for Muscle Spasm and Spasticity - p. 59 35. 29: Local Anesthetics - p. 61 36. 30: General Anesthetics - p. 63 37. 31: Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics - p. 66 38. 32: Pain Management in Patients with Cancer - p. 69 39. 33: Drugs for Headache - p. 71 40. 34: Antipsychotic Agents and Their Use in Schizophrenia - p. 74 41. 35: Antidepressants - p. 76 42. 36: Drugs for Bipolar Disorder - p. 80 43. 37: Sedative-Hypnotic Drugs - p. 82 44. 38: Management of Anxiety Disorders - p. 85 45. 39: Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder - p. 88 46. 40: Substance Use Disorders I: Basic Considerations - p. 91 47. 41: Substance Use Disorders II: Alcohol - p. 93 48. 42: Substance Use Disorders III: Nicotine and Smoking - p. 96 49. 43: Substance Use Disorders IV: Major Drugs of Abuse other Than Alcohol and Nicotine - p. 98 50. Unit Six: Drugs that Affect Fluid and Electrolyte Balance - p. 100 51. 44: Diuretics - p. 101 52. 45: Agents Affecting the Volume and Ion Content of Body Fluids - p. 105 53. Unit Seven: Drugs that Affect the Heart, Blood Vessels, and Blood - p. 107 54. 46: Review of Hemodynamics - p. 108 55. 47: Drugs Acting on the Renin-Angiotensin-Aldosterone System - p. 110 56. 48: Calcium Channel Blockers - p. 113 57. 49: Vasodilators - p. 116 58. 50: Drugs for Hypertension - p. 118 59. 51: Drugs for Heart Failure - p. 121 60. 52: Antidysrhythmic Drugs - p. 125 61. 53: Drugs that help Normalize Cholesterol and Triglyceride Levels - p. 128 62. 54: Drugs for Angina Pectoris - p. 131 63. 55: Anticoagulant, Antiplatelet, and Thrombolytic Drugs - p. 134 64. 56: Management of ST-Elevation Myocardial Infarction - p. 138 65. 57: Drugs for Hemophilia - p. 141 66. 58: Drugs for Deficiency Anemias - p. 143 67. 59: Hematopoietic Agents - p. 146 68. Unit Eight: Drugs for Endocrine Disorders - p. 148 69. 60: Drugs for Diabetes Mellitus - p. 149 70. 61: Drugs for Thyroid Disorders - p. 153 71. 62: Drugs Related to Hypothalamic and Pituitary Function - p. 156 72. 63: Drugs for Disorders of the Adrenal Cortex - p. 159 73. Unit Nine: Women’s Health - p. 161 74. 64: Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications - p. 162 75. 65: Birth Control - p. 164 76. 66: Drug Therapy of Infertility - p. 167 77. 67: Drugs that Affect Uterine Function - p. 169 78. Unit Ten: Men’s Health - p. 171 79. 68: Androgens - p. 172 80. 69: Drugs for Male Sexual Dysfunction and Benign Prostatic Hyperplasia - p. 174 81. Unit Eleven: Anti-Inflammatory, Antiallergic, and Immunologic Drugs - p. 176 82. 70: Review of the Immune System - p. 177 83. 71: Childhood Immunization - p. 179 84. 72: Immunosuppressants - p. 183 85. 73: Antihistamines - p. 186 86. 74: Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen - p. 188 87. 75: Glucocorticoids in Nonendocrine Disorders - p. 191 88. Unit Twelve: Drugs for Bone and Joint Disorders - p. 192 89. 76: Drug Therapy of Rheumatoid Arthritis - p. 193 90. 77: Drug Therapy of Gout - p. 196 91. 78: Drugs Affecting Calcium Levels and Bone Mineralization - p. 198 92. Unit Thirteen: Respiratory Tract Drugs - p. 201 93. 79: Drugs for Asthma and Chronic Obstructive Pulmonary Disease - p. 202 94. 80: Drugs for Allergic Rhinitis, Cough, and Colds - p. 206 95. Unit Fourteen: Gastrointestinal Drugs - p. 208 96. 81: Drugs for Peptic Ulcer Disease - p. 209 97. 82: Laxatives - p. 212 98. 83: Other Gastrointestinal Drugs - p. 215 99. Unit Fifteen: Nutrition - p. 217 100. 84: Vitamins - p. 218 101. 85: Drugs for Weight Loss - p. 221 102. 86: Complementary and Alternative Therapy - p. 223 103. Unit Sixteen: Chemotherapy of Infectious Diseases - p. 225 104. 87: Basic Principles of Antimicrobial Therapy - p. 226 105. 88: Drugs That Weaken the Bacterial Cell Wall I: Penicillins - p. 229 106. 89: Drugs That Weaken the Bacterial Cell Wall II: Other Drugs - p. 232 107. 90: Bacteriostatic Inhibitors of Protein Synthesis: Tetracyclines, Macrolides, and Others - p. 235 108. 91: Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis - p. 238 109. 92: Sulfonamide Antibiotics and Trimethoprim - p. 241 110. 93: Drug Therapy of Urinary Tract Infections - p. 244 111. 94: Antimycobacterial Agents - p. 246 112. 95: Miscellaneous Antibacterial Drugs - p. 250 113. 96: Antifungal Agents - p. 253 114. 97: Antiviral Agents I: Drugs for Non-HIV Viral Infections - p. 256 115. 98: Antiviral Agents II: Drugs for HIV Infection - p. 259 116. 99: Drug Therapy for Sexually Transmitted Infections - p. 262 117. 100: Antiseptics and Disinfectants - p. 265 118. Unit Seventeen: Chemotherapy of Parasitic Diseases - p. 266 119. 101: Anthelmintics - p. 267 120. 102: Antiprotozoal Drugs I: Antimalarial Agents - p. 269 121. 103: Antiprotozoal Drugs II: Miscellaneous Agents - p. 272 122. 104: Ectoparasiticides - p. 274 123. Unit Eighteen: Cancer Chemotherapy - p. 275 124. 105: Basic Principles of Cancer Chemotherapy - p. 276 125. 106: Anticancer Drugs I: Cytotoxic Agents - p. 278 126. 107: Anticancer Drugs II: Noncytotoxic Agents - p. 281 127. Unit Nineteen: Miscellaneous Drugs and Therapies - p. 284 128. 108: Drugs for the Eye - p. 285 129. 109: Drugs for the Skin - p. 288 130. 110: Drugs for the Ear - p. 292 131. Unit Twenty: Toxicology - p. 293 132. 111: Management of Poisoning - p. 294 133. 112: Potential Weapons of Biologic, Radiologic, and Chemical Terrorism - p. 297 134. Answer Key - p. 301 135. Chapter 1 - p. 301 136. Chapter 2 - p. 301 137. Chapter 3 - p. 301 138. Chapter 4 - p. 301 139. Chapter 5 - p. 302 140. Chapter 6 - p. 302 141. Chapter 7 - p. 302 142. Chapter 8 - p. 302 143. Chapter 9 - p. 302 144. Chapter 10 - p. 303 145. Chapter 11 - p. 303 146. Chapter 12 - p. 303 147. Chapter 13 - p. 303 148. Chapter 14 - p. 303 149. Chapter 15 - p. 304 150. Chapter 16 - p. 304 151. Chapter 17 - p. 304 152. Chapter 18 - p. 304 153. Chapter 19 - p. 304 154. Chapter 20 - p. 305 155. Chapter 21 - p. 305 156. Chapter 22 - p. 305 157. Chapter 23 - p. 305 158. Chapter 24 - p. 306 159. Chapter 25 - p. 306 160. Chapter 26 - p. 306 161. Chapter 27 - p. 306 162. Chapter 28 - p. 307 163. Chapter 29 - p. 307 164. Chapter 30 - p. 307 165. Chapter 31 - p. 308 166. Chapter 32 - p. 308 167. Chapter 33 - p. 308 168. Chapter 34 - p. 309 169. Chapter 35 - p. 309 170. Chapter 36 - p. 310 171. Chapter 37 - p. 310 172. Chapter 38 - p. 311 173. Chapter 39 - p. 311 174. Chapter 40 - p. 311 175. Chapter 41 - p. 311 176. Chapter 42 - p. 312 177. Chapter 43 - p. 312 178. Chapter 44 - p. 312 179. Chapter 45 - p. 313 180. Chapter 46 - p. 313 181. Chapter 47 - p. 314 182. Chapter 48 - p. 314 183. Chapter 49 - p. 315 184. Chapter 50 - p. 315 185. Chapter 51 - p. 315 186. Chapter 52 - p. 316 187. Chapter 53 - p. 316 188. Chapter 54 - p. 317 189. Chapter 55 - p. 317 190. Chapter 56 - p. 317 191. Chapter 57 - p. 318 192. Chapter 58 - p. 318 193. Chapter 59 - p. 319 194. Chapter 60 - p. 319 195. Chapter 61 - p. 319 196. Chapter 62 - p. 320 197. Chapter 63 - p. 320 198. Chapter 64 - p. 321 199. Chapter 65 - p. 321 200. Chapter 66 - p. 321 201. Chapter 67 - p. 321 202. Chapter 68 - p. 322 203. Chapter 69 - p. 322 204. Chapter 70 - p. 323 205. Chapter 71 - p. 323 206. Chapter 72 - p. 323 207. Chapter 73 - p. 324 208. Chapter 74 - p. 324 209. Chapter 75 - p. 324 210. Chapter 76 - p. 325 211. Chapter 77 - p. 325 212. Chapter 78 - p. 325 213. Chapter 79 - p. 326 214. Chapter 80 - p. 327 215. Chapter 81 - p. 327 216. Chapter 82 - p. 327 217. Chapter 83 - p. 328 218. Chapter 84 - p. 328 219. Chapter 85 - p. 329 220. Chapter 86 - p. 329 221. Chapter 87 - p. 329 222. Chapter 88 - p. 330 223. Chapter 89 - p. 330 224. Chapter 90 - p. 331 225. Chapter 91 - p. 331 226. Chapter 92 - p. 332 227. Chapter 93 - p. 332 228. Chapter 94 - p. 332 229. Chapter 95 - p. 333 230. Chapter 96 - p. 333 231. Chapter 97 - p. 333 232. Chapter 98 - p. 334 233. Chapter 99 - p. 334 234. Chapter 100 - p. 335 235. Chapter 101 - p. 335 236. Chapter 102 - p. 335 237. Chapter 103 - p. 336 238. Chapter 104 - p. 336 239. Chapter 105 - p. 336 240. Chapter 106 - p. 336 241. Chapter 107 - p. 337 242. Chapter 108 - p. 337 243. Chapter 109 - p. 338 244. Chapter 110 - p. 338 245. Chapter 111 - p. 339 246. Chapter 112 - p. 339

Indice
Autores
Muestra
Ficha Técnica